EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Evaxion A/S
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$3.33+0.50 (+17.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Evaxion A/S statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Market Cap | $1.39B | $197.05M |
| Enterprise Value | $1.37B | $106.56M |
| PS Ratio | 184.46 | 3.93 |
Enterprise value
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| EV / Sales | 182.11 | 2.69 |
Income (trailing twelve months)
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Revenue | $7.53M | $57.94M |
| Operating Income | -$9.23M | -$21.44M |
| Pretax Income | -$8.62M | -$14.45M |
| Net Income | -$7.71M | -$22.46M |
| EBITDA | -$9.23M | -$16.91M |
Margins
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Operating Margin | -122.7% | -44.5% |
| Pretax Margin | -114.4% | -13.0% |
| Profit Margin | -102.4% | -39.2% |
| EBITDA Margin | -122.7% | -31.3% |
| FCF Margin | -88.2% | -8.85% |
Returns
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Return on Assets (ROA) | -37.7% | -41.0% |
| Return on Capital Employed (ROCE) | -38.2% | -37.8% |
Growth
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 125.1% | 6.01% |
Balance sheet
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $23.23M | $62.42M |
| Total Debt | $5.54M | $120.13M |
| Net Cash (Debt) | $17.70M | $15.68M |
| Net Cash Per Share | $0.04 | $0.65 |
| Working Capital | $20.64M | $75.77M |
Financial position
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Current Ratio | 5.85 | 3.30 |
| Quick Ratio | 5.46 | 2.39 |
| Interest Coverage | -2.31 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.63M | -$12.35M |
| Capital Expenditures | -$11.00K | -$1.06M |
| Free Cash Flow | -$6.64M | -$20.28M |
| FCF Per Share | -$0.02 | -$0.41 |
Efficiency
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Asset Turnover | 0.37 | 0.38 |
| Revenue Per Employee | $167.29K | $398.96K |
| Profits Per Employee | -$171.27K | -$732.08K |
| Employee Count | 45 | 73 |
Dividends and yields
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Earnings Yield | -0.56% | -21.2% |
| FCF Yield | -0.48% | -7.64% |
| Buyback Yield | -1.67% | -0.58% |
| Shareholder Yield | -1.67% | 0.00% |
Shares
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Shares Outstanding | 417,011,000 | 59,128,900 |
| Shares Change (YoY) | 497.3% | 11.1% |
| Float | 402,448,000 | 48,744,500 |
| Shares Held by Insiders | 3.49% | 11.8% |
| Shares Held by Institutions | 0.38% | 59.4% |
Taxes
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Income Tax | -$908.00K | $91.50K |
Scores
| Measure | Evaxion A/S | Industry median |
|---|---|---|
| Altman Z-Score | 67.13 | 0.10 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Evaxion A/S's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.